Entera Bio (ENTX): Operating Profitability

Public company logo of Entera Bio (ENTX)

High patent barriers in the field of oral biologics and stringent FDA oversight protect the business of Entera Bio Ltd. (ENTX). The operating profit margin line on the GURU.Markets chart shows that the current mark is 0.00. The lack of stable cash flow and the clinical stage create inertia, which Entera Bio Ltd. (ENTX) offsets through partnerships to develop tablet-based treatments for osteoporosis and hormone deficiency.

ENTX: Entera Bio Ltd. Operating Margin 07/04/2022 - 11/19/2026

Comprehensive metric breakdowns and analytics for Entera Bio Ltd (ENTX)

- share price and consensus valuation forecast:
Initial company analysis:ENTX, Entera Bio Ltd.
Finished products of Entera Bio

The long-term sustainability of Entera Bio Ltd. (ENTX) is determined by its ability to generate profit from its core business, as reflected by the estimated operating margin calculated as the ratio of operating income to revenue before taxes and interest. This indicator demonstrates cost management efficiency, which in the case of Entera Bio Ltd. (ENTX) is supported by patents for the ProNeura platform, creating high product value and protecting margins from competition.

Competitors of Entera Bio Ltd.

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|Aquestive Therapeutics, Inc. - Operating Margin|scpharmaceuticals.com - Operating Profit Ratio|Tectonic (TECX) - Operating Profitability|Operating Sales Margin Tonix Pharmaceuticals Inc.|Operating Profitability sxtchina.com|Operating Sales Margin Eupraxia Pharmaceuticals (EPRX)|Operating Margin BHST|EXOZ - Operating Return on Sales|Oramed - Operating Sales Margin|Operating Profitability Margin MindWalk Therapeutics|ABVC: Operating Sales Margin|CPIX - Operating Margin|QNTM (Quantum BioPharma) - Operating Sales Margin|Operating Profit Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operating Margin|Operating Margin ranitherapeutics.com|Operating Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Return on Sales by Operating Profit|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.